业绩扭亏为盈股价却大幅下挫,百济神州让出医药股市值第一位置

民商财经
Yesterday

本文授权来自《中国民商》作者:郑勇康编辑:张佳茗从今年1月中旬的股价约319元到3月9日收盘价232.89元,创新药龙头股百济神州的股价跌幅约为26%。截止3月9日收盘,百济神州的总市值约为3,588亿元,而恒瑞医药的当前总市值约为3,646亿元,百济神州已经退居医药股市值第二位。然而,在被恒瑞医药“反超”的背后,百济神州仍然交出了一份优异的业绩表现。2月26日晚,百济神州发布了2025年业绩快报...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10